Company Filing History:

8 out of 1,384

The Brigham and Women's Hospital, Inc.

patents

1 out of 72

Creative Biomolecules, Inc.

where one patent can have more than one assignee

Years Active: 1982-1993

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5239094 - Tetrahydro-S-21-Br (1993-08-24),

2. 5234908 - Method of treating gastrointestinal ulcers with platelet derived growth (1993-08-10),

3. 5223521 - Pyrazole and thiozole derivatives for treatment of gastrointestinal (1993-06-29),

4. 5214066 - Method for producing an animal model for inflammatory bowel disease (1993-05-25),

5. 5066496 - Composition and method for treatment of gastric and duodenal ulcers and (1991-11-19),

6. 4891356 - Proteinase inhibitors for treatment of gastrointestinal ulcer disease (1990-01-02),

7. 4612302 - Clinical use of somatostatin analogues (1986-09-16),

8. 4569926 - Stimulation of phagocytosis with somatostatin (1986-02-11),

9. 4366148 - Use of somatostatin in the prevention and cure of vascular, membrane, or (1982-12-28),

Title: Sandor Szabo: Innovator in Angiotropic Steroids

Introduction

Sandor Szabo is a notable inventor based in Brookline, MA, who has made significant contributions to the field of pharmaceuticals. He holds a total of nine patents, showcasing his innovative approach to medical treatments.

Latest Patents

Among his latest patents is Tetrahydro-S-21-Br, which is directed to novel angiotropic (angiogenic and angiostatic) steroids that are halogenated in the 21 position. This invention also includes novel methods for treating gastrointestinal ulcers through the administration of these angiotropic steroids. Another significant patent involves a method for treating ulcers of the gastrointestinal tract in mammals, which includes administering a therapeutically effective amount of Platelet-Derived Growth Factor (PDGF) to the gastrointestinal tract.

Career Highlights

Throughout his career, Sandor Szabo has worked with esteemed organizations such as Brigham and Women's Hospital and Creative Biomolecules. His work has focused on advancing medical treatments and improving patient outcomes through innovative solutions.

Collaborations

Sandor has collaborated with notable individuals in his field, including Klaus H. Usadel and Klaus W. Usadel, contributing to the advancement of research and development in pharmaceuticals.

Conclusion

Sandor Szabo's contributions to the field of angiotropic steroids and gastrointestinal treatments highlight his role as a significant innovator in the medical industry. His patents reflect a commitment to improving healthcare through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com